Current Report Filing (8-k)
May 10 2022 - 7:37AM
Edgar (US Regulatory)
0001725255
false
0001725255
2022-05-10
2022-05-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 10, 2022
AdaptHealth
Corp.
(Exact name
of registrant as specified in its charter)
Delaware | |
001-38399 | |
82-3677704 |
(State or other jurisdiction of
incorporation) | |
(Commission File Number) | |
(IRS Employer Identification No.) |
220 West Germantown Pike, Suite 250
Plymouth Meeting, PA |
|
19462 |
(Address of principal executive offices) |
|
(Zip Code) |
|
|
|
(610) 630-6357 |
(Registrant’s telephone number, including area code)
|
Not Applicable |
(Former name or former address, if changed
since last report.) |
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to
Section 12(b) of the Act:
Title of each
class |
Trading Symbol(s) |
Name of each
exchange on which registered |
Common Stock, par value $0.0001 per share
|
AHCO
|
The
Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02. Results of Operations and Financial Condition.
The following information is furnished pursuant to Regulation FD.
On May 10, 2022, AdaptHealth Corp. (the “Company”) issued
a press release (the “Press Release”) announcing financial results for the quarter ended March 31, 2022. A copy of the Press
Release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information in this Item 2.02 (including Exhibit 99.1) shall not
be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended (the “Securities Act”), or the Exchange Act, regardless of any general incorporation language in such
filing, unless expressly incorporated by reference in such filing.
Item 9.01. Financial Statements and Exhibits.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
Dated: May 10, 2022
|
AdaptHealth Corp. |
|
|
|
By: |
/s/ Jason Clemens |
|
|
Name: Jason Clemens |
|
|
Title: Chief Financial Officer |
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Aug 2024 to Sep 2024
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Sep 2023 to Sep 2024